Humabs BioMed Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 37

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Humabs BioMed General Information

Description

Developer of human monoclonal antibodies created to treat a wide range of serious infections in the human body. The company's human monoclonal antibodies have passed natural selection by the human immune system in response to viral and bacterial diseases, in addition, it also developed anti-infective immunotherapies for the treatment of induce protective and therapeutic immune responses which solutions are non-existent or inadequate, enabling patients and pharmaceutical companies to get drugs for the treatment of rare diseases.

Contact Information

Website
www.humabs.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Biotechnology
Acquirer
Corporate Office
  • Via Mirasole 1
  • 6500 Bellinzona
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Humabs BioMed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Humabs BioMed‘s full profile, request access.

Request a free trial

Humabs BioMed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of human monoclonal antibodies created to treat a wide range of serious infections in the human body. The comp
Other Pharmaceuticals and Biotechnology
Bellinzona, Switzerland
37 As of 2021
000000&0

00000

t aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vol
0000000000000
Thousand Oaks, CA
00000 As of 0000
000.00
000000000 000.00

000000

e et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ull
0000 000000000
Newcastle upon Tyne, United Kingdom
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Humabs BioMed Competitors (82)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amgen Formerly PE-Backed Thousand Oaks, CA 00000 000.00 000000000 000.00
Iksuda Therapeutics Venture Capital-Backed Newcastle upon Tyne, United Kingdom 00 000.00 00000000000 000.00
OncoResponse Venture Capital-Backed Houston, TX 00 00000 0000000000 00000
Rhythm Pharmaceuticals Formerly VC-backed Boston, MA 000 00000 000000000 00000
Meditope Biosciences Venture Capital-Backed Pasadena, CA 0 00.000 000000000000 00.000
You’re viewing 5 of 82 competitors. Get the full list »

Humabs BioMed Patents

Humabs BioMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3218489-A1 Engineered polypeptides Pending 24-May-2021 00000000000
AU-2022280767-A1 Engineered polypeptides Pending 24-May-2021 00000000000
CA-3210502-A1 Antibodies against respiratory syncytial virus, human metapneumovirus and pneumonia virus of mice and methods of using the same Pending 09-Feb-2021 00000000000
EP-4291575-A1 Antibodies against respiratory syncytial virus, human metapneumovirus and pneumonia virus of mice and methods of using the same Pending 09-Feb-2021 00000000000
JP-2024506321-A Antibodies against respiratory syncytial virus and other paramyxoviruses and their use Pending 09-Feb-2021
To view Humabs BioMed’s complete patent history, request access »

Humabs BioMed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »